Saba Capital Management, L.P. bought HQL
June 6, 2024 · Form 4 insider transaction
Saba Capital Management, L.P. bought 9,598 shares of Abrdn Life Sciences Investors at $13.80 per share, a transaction worth $132.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,598
Price
$13.80
Total value
$132.5K
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJune 6, 2024
Filing dateJune 10, 2024
Shares owned after3,389,706
OwnershipIndirect
10b5-1 planNo
AmendedNo